Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System

NCT03341117 is registered in ClinicalTrials.gov with Centro Universitario de Ciencias de la Salud, Mexico as lead sponsor.

NCT NCT03341117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System
Lead sponsor
Centro Universitario de Ciencias de la Salud, Mexico
Phase
Phase 3
Overall status
Completed
Start date
December 2, 2014
Completion date
December 2, 2016
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antioxidant enzyme system, diabetes mellitus, type 2